All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Short-course AIT in a porcine allergic model by prolonged and enhanced oromucosal allergen presentation

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F20%3AN0000184" target="_blank" >RIV/00027162:_____/20:N0000184 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Short-course AIT in a porcine allergic model by prolonged and enhanced oromucosal allergen presentation

  • Original language description

    Newborn piglets sensitized intraperitoneally with the common egg allergen ovalbumin (OVA) were sublingually treated five times using a dose ascending administration schedule with a proprietary mouth patch containing high dose of OVA, formulated with immune tolerogenic particles derived from the probiotic bacterium Lactococcus lactis. Physical symptoms were monitored to determine the allergic response. Immunologic assessment was conducted through use of intradermal testing of the allergenic response to OVA. Cryocuts of mucosal and regional lymphoid tissues were analysed by confocal fluorescence microscopy for uptake and migration of OVA allergen and bacterial particles. Following sublingual patch administrations, the pigs were analysed by intradermal allergy testing and for IgE.

  • Czech name

  • Czech description

Classification

  • Type

    O - Miscellaneous

  • CEP classification

  • OECD FORD branch

    30102 - Immunology

Result continuities

  • Project

    <a href="/en/project/EF15_003%2F0000495" target="_blank" >EF15_003/0000495: FIT (Pharmacology, Immunotherapy, nanoToxicology)</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů